Trisenox is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocytic leukaemia (APL). 

The global Trisenox market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Trisenox volume and value at global level, regional level and company level. From a global perspective, this report represents overall Trisenox market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Trisenox in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Trisenox manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Cephalon
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
1mg/ml
2mg/ml

Segment by Application
Hospital
Pharmacy